Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)
PHASE2
This study is a Phase IIa, randomized, multi-site, two-arm, double-blinded ...
Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.
N/A
The RELATIVITY study is a nationwide, multicenter, ambispective observation...
Status
Active Not Recruiting
Location
Hospital Universitario de Burgos
Start Date
2024-12-31
Trial ID
NCT07703748
Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.
PHASE3
The purpose of this study is to evaluate if offering long-acting injectable...
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
PHASE3
This Antiretroviral Therapy as Long Acting Suppression every 2 Months (ATLA...